Oral Thin Film Market
Oral Thin Film Market Study by Oromucosal and Orodispersable for Pain Management, Neurological Disorders, Nausea & Vomiting, and Opioid Dependence from 2024 to 2034
Analysis of Oral Thin Film Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Oral Thin Film Market Outlook (2024 to 2034)
The global oral thin film market size is set to be valued at US$ 3.7 billion in 2024 and thereafter expand at a CAGR of 8.9% to end up at a size of US$ 8.7 billion by 2034.
Oral thin films (OTFs) are drug delivery systems designed to dissolve or disintegrate rapidly in the mouth. They offer an alternative to traditional oral dosage forms such as tablets and capsules. OTFs are composed of hydrophilic polymers that enable them to dissolve quickly when they come in contact with saliva.
The oral route is the most preferred method for administering therapeutic drugs because it is simple to use, has a cheap cost of therapy, and has a high rate of patient compliance. Tablets and capsules are the most widely used oral solid dose forms. Geriatric, pediatric, and bedridden patients, however, have trouble swallowing typical oral dosage forms.
Key Market Growth Drivers
- Rapid drug action is achieved through oral disintegrating films, which dissolve medication in the buccal cavity. Over the past decade, oral thin films have gained commercial significance in both generic and branded markets, establishing themselves as a global business asset.
- Administering drugs through the oral mucosa shows promise for providing a quick onset of action or enhanced bioavailability for medications subject to high first-pass metabolism. There is growing interest in developing orally fast disintegrating strips that allow rapid absorption directly into the systemic circulation via the oral mucosa, thereby expanding the oral thin film market.
- OTFs bypass the gastrointestinal (GI) tract as they are absorbed directly into the systemic circulation through the mouth. This bypass offers several significant advantages, creating new market opportunities.
- Primary benefit of bypassing the GI tract is the elimination of many common side effects associated with other orally delivered medications, such as pills or chewable tablets. Many patients experience gastrointestinal distress from such medications, but OTFs are less likely to cause this issue because they are not ingested, contributing to oral thin film market growth.
- Oral thin films are also considered a form of 'precision medicine', with perforations in a single film allowing for accurate and flexible dosing. These products are appealing to adults who need partial doses of medication due to their dosing flexibility. While pediatric applications benefit from this flexibility since children require smaller and more variable dosages than adults, OTFs also suit various other applications, which is expected to drive market expansion in the future.
| Report Attribute | Details |
|---|---|
| Oral Thin Film Market Size (2024E) | US$ 3.7 Billion |
| Projected Market Value (2034F) | US$ 8.7 Billion |
| Global Market Growth Rate (2024 to 2034) | 8.9% CAGR |
| Latin America Market Growth Rate (2024 to 2034) | 6.4% CAGR |
| North America Market Growth Rate (2034) | 11.1% CAGR |
| Revenue from Hospital Pharmacies (2024) | US$ 2.01 Billion |
| Sales of Oromucosal Films (2024) | US$ 3.05 Billion |
| Key Companies Profiled | ZIM Laboratories Ltd.; Indivior Plc.; Aquestive Therapeutics Inc.; LIVKON Pharmaceuticals Pvt. Ltd.; Sunovion Pharmaceuticals Inc.; NAL Pharma; CURE Pharmaceutical; IntelGenx Corp.; Kyu Pharmaceutical Co. Ltd.; C.L. Pharm. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Makes Oral Thin Films Particularly Patient-Friendly?
“Larger Surface Area of OTFs for Faster Wetting, Disintegration, and Dissolution”
Oral thin films are increasingly being used as a drug delivery platform due to their ability to incorporate poorly soluble medicines; however, their primary advantage is their patient-friendly nature. The significantly larger surface area of OTFs compared to conventional drug delivery methods allows for faster wetting, disintegration, and dissolution. Saliva alone is sufficient to diffuse or spread the medication load of these films; no water, chewing, or swallowing is needed. To appeal to young children, OTFs can also be made with pleasant colors and flavors. These films are easy to handle and transport.
Production of oral thin films is facilitated by their final form, and advancements in solvent-free, aqueous-based, powderless film manufacturing allow for continuous, around-the-clock production. This method is faster and involves only two steps: mixing and casting. In contrast, making tablets and capsules is a much more complex process. Drugs with expiring patents are also excellent candidates for reformulation into OTFs, as doing so can provide an additional three years of market exclusivity if a unique oral film application is approved.
Which Limitations of Oral Thin Films are Restricting Their Adoption?
“Sensitivity to Moisture and Temperature Variations and Limited Medication Load Capacity”
As a novel and evolving mode of drug delivery, OTFs come with associated challenges. Only recently have OTFs begun incorporating medications that are not water-soluble. Tablets and capsules typically include components to aid in drug dissolution. In contrast, OTFs primarily use polymers to enhance a drug's solubility, making them a more efficient delivery mechanism.
To improve the solubility of water-insoluble medications in OTFs and thereby increase the functionality of OTF technology, scientists are exploring new particle engineering techniques. Another limitation of OTFs is their capacity to carry only a small medication load of 10 to 20 mg. Additionally, due to their larger surface area, OTFs are more susceptible to humidity and temperature. All of these challenges are restricting the expansion of the oral thin film market size.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
The market in East Asia is projected to grow at a significant rate during the forecast period driven by the presence of local and global oral thin film manufacturers, an increase in the geriatric population, and a surge in healthcare expenditure.
North America is poised to hold a substantial global oral thin film market share of 33.2% by 2034. Increased R&D investments, as well as the approval and launch of new oral thin films, are driving market growth in the region.
Which Conditions are Being Treated by Medications in Oral Thin Film Form in the United States?
“Rising Use of Medications in OTF Form in Treating Schizophrenia, ALS, and Opioid Addiction”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.07 Billion |
| Growth Rate (2024 to 2034) | 10.5% CAGR |
| Projected Value (2034F) | US$ 2.91 Billion |
Oral thin films are being extensively used in the United States, mostly for the treatment of illnesses such as schizophrenia, ALS, and opioid addiction. In addition, many more OTFs are being developed to address chronic illnesses like migraines and Alzheimer's disease. The Food and Drug Administration (FDA) is currently approving over 11 oral film products.
OTFs have proven to be a highly effective method for major pharmaceutical companies to protect their products once their patents expire. With patent protection lasting up to 20 years, new oral film applications of reformulated medications can gain an additional 3 years of market exclusivity, which can be extended up to 7 years if approved as orphan drugs by the FDA.
How Do Oral Thin Films Align with Cultural Preferences in Japan?
“OTFs Offering Discreet and Non-Invasive Way to Take Medication”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 202 Million |
| Growth Rate (2024 to 2034) | 2.9% CAGR |
| Projected Value (2034F) | US$ 268.8 Million |
Japan has a growing aging population. Oral thin films (OTFs) are preferred by older adults who have difficulty swallowing pills or capsules, making them an ideal dosage form for this group. OTFs dissolve quickly in the mouth and do not require water, offering convenience and ease of administration, especially for people on the go or those with mobility issues. This convenience factor is particularly important in Japan's fast-paced urban environment.
Manners and etiquette are highly valued in Japanese culture, including how medication is taken. OTFs provide a discreet and non-invasive way to take medication, aligning with cultural preferences for subtlety and politeness. Japan is also well-known for its advanced technology and innovative healthcare practices, which is also a key oral thin film market trend.
Category-wise Insights
Oral thin films are being widely used for treating neurological disorders and pain management. These disorders are poised to account for market shares of 28.4% and 36%, respectively in 2024. In terms of product type, oromucosal films are set to hold a substantial market share of 82.2% in 2024.
Hospital pharmacies are expected to hold a market share of 54.2% in terms of distribution channels in 2024. Retail pharmacies are set to account for a market share of 35.3% in 2024, followed by online pharmacies with an estimated share of around 10%.
Why are Medications in OTF Form Widely Used for Treating Neurological Disorders?
“Risk of Choking and Respiratory Cycle Disturbances with Solid Drugs”
| Attribute | Neurological Disorders |
|---|---|
| Segment Value (2024E) | US$ 1.33 Billion |
| Growth Rate (2024 to 2034) | 8.6% CAGR |
| Projected Value (2034F) | US$ 3.05 Billion |
OTFs are being extensively used to treat a range of neurological illnesses, including schizophrenia and Alzheimer's disease. The majority of these patients-4 out of 5-prefer orally disintegrating dosage forms to traditional solid oral dosage forms.
In addition to concerns about choking and respiratory cycle disturbances, people with neurological diseases and central nervous system disorders often have trouble chewing or swallowing solid drugs. Consequently, oral thin films are growing in popularity. Medical professionals highly favor these films as routes of administration due to their quick hydration and disintegration rates.
How are Retail Pharmacies Contributing to Sales of Oral Thin Films?
“Increased Convenience in Selecting Diverse Range of Oral Thin Film Products”
| Attribute | Retail Pharmacies |
|---|---|
| Segment Value (2024E) | US$ 1.31 Billion |
| Growth Rate (2024 to 2034) | 8.6% CAGR |
| Projected Value (2034F) | US$ 2.99 Billion |
The retail pharmacies distribution channel segment is expected to account for a leading share in 2024. Easy availability of a wide range of products, home delivery services, and an increase in the number of retail pharmacies in developing countries are all driving this segment forward. The expansion of the e-commerce sector and the increased convenience of selecting from a diverse range of oral thin film products are also benefitting patients.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Growing demand for effective drug delivery systems is projected to provide significant growth opportunities for key players in the oral thin films market. Companies are investing heavily in research and development to create more effective and patient-friendly OTFs. This includes enhancing drug solubility and developing multi-layered films for complex drug regimens.
- IntelGenx Corp. announced in October 2022 that the first-in-human clinical study of an oral thin film psychedelic drug candidate would begin in collaboration with Atai Life Sciences.
- In June 2021, Shilpa Medicare Ltd., a research-led global integrated pharmaceutical company, announced the launch of Oral Thin Film formulation, a pediatric dose of paracetamol oral thin film, under the brand name Molshil. Shilpa Medicare Ltd. has received approval for Molshil Oral Thin Films after meeting all bioequivalence requirements.
- In March 2021, Aquestive Therapeutics Inc. demonstrated an extensive review of the science, clinical results, and development strategy of its PharmFilm oral sublingual film for administering epinephrine. This product is touted to effectively treat allergic reactions, including anaphylaxis.
Fact.MR provides detailed information about the price points of key providers of oral thin films positioned across the world, sales growth, production capacity, and speculative technological expansion, in this updated market report.
Segmentation of Oral Thin Film Market Research
-
By Product Type :
- Oromucosal
- Orodispersible
-
By Indication :
- Pain Management
- Neurological Disorders
- Nausea & Vomiting
- Opioid Dependence
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
By Region :
- North America
- Latin America
- Middle East & Africa
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Indication 6.2. Product Type 6.3. Distribution Channel 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Indication 7.1. Pain Management 7.2. Neurological Disorders 7.3. Nausea & Vomiting 7.4. Opioid Dependence 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product Type 8.1. Oromucosal 8.2. Orodispersible 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel 9.1. Hospital Pharmacies 9.2. Retail Pharmacies 9.3. Online Pharmacies 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. Middle East & Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Indication, Product Type, Distribution Channel, and Region for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. ZIM Laboratories Ltd. 20.2. Indivior Plc. 20.3. Aquestive Therapeutics Inc. 20.4. LIVKON Pharmaceuticals Pvt. Ltd. 20.5. Sunovion Pharmaceuticals Inc. 20.6. NAL Pharma 20.7. CURE Pharmaceutical 20.8. IntelGenx Corp. 20.9. Kyu Pharmaceutical Co. Ltd. 20.10. C.L. Pharm 21. Assumptions and Acronyms Indicationd 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 37: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Western Europe Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 41: Western Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 42: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 43: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 44: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 45: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 46: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 47: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 49: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 50: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: Eastern Europe Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 53: Eastern Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 54: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 55: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 56: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 57: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 58: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 59: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 60: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 61: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 62: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: East Asia Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 65: East Asia Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 66: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 67: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 68: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 71: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 72: East Asia Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 73: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 74: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: South Asia & Pacific Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 77: South Asia & Pacific Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 78: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 79: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 80: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 81: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 82: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 83: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 84: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 85: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 86: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 87: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 88: MEA Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 89: MEA Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 90: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 91: MEA Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 92: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 93: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 94: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 95: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 96: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 50: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 52: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Western Europe Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 57: Western Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 58: Western Europe Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 59: Western Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 60: Western Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 61: Western Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 62: Western Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 63: Western Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 64: Western Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 66: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 70: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 71: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: Eastern Europe Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 74: Eastern Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 76: Eastern Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 77: Eastern Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 78: Eastern Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 79: Eastern Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 80: Eastern Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 81: Eastern Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 82: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 83: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 84: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 85: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 86: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 87: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 88: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 89: East Asia Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 90: East Asia Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 91: East Asia Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 92: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 93: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 94: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 95: East Asia Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 96: East Asia Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 97: East Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 98: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 99: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 100: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 101: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 102: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 103: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 104: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 105: South Asia & Pacific Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 106: South Asia & Pacific Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 107: South Asia & Pacific Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 108: South Asia & Pacific Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 109: South Asia & Pacific Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 110: South Asia & Pacific Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 111: South Asia & Pacific Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 112: South Asia & Pacific Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 113: South Asia & Pacific Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 114: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 115: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 116: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 117: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 118: MEA Market Share Analysis by Country, 2024 & 2034
Figure 119: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 120: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 121: MEA Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 122: MEA Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 123: MEA Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 124: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 125: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 126: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 127: MEA Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 128: MEA Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 129: MEA Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the market for oral thin films in 2024?
Worldwide sales of oral thin films are estimated at US$ 3.7 billion in 2024.
What are the sales projections for oral thin films over the decade?
The global oral thin film market is forecasted to expand at 8.9% CAGR to reach US$ 8.7 billion by 2034.
Which country has a significant market for oral thin films?
The United States is estimated at a market value of US$ 1.07 billion in 2024.
What is the market size of oral thin films in China?
The market in China is forecasted to reach US$ 317.3 million in 2024.
How much are the sales of oral thin films from hospital pharmacies?
Sales of oral thin films from hospital pharmacies are calculated at US$ 2.01 billion in 2024.
What is the share of Japan in the East Asia market?
Japan accounts for 31.1% market share in the East Asia region in 2024.
Who are the leaders in the business of oral thin films?
LIVKON Pharmaceuticals Pvt. Ltd., Sunovion Pharmaceuticals Inc., NAL Pharma, CURE Pharmaceutical, and Intel Genx Corp. are some of the key players in the market.
Oral Thin Film Market